A.L. Vataire

664 total citations
34 papers, 478 citations indexed

About

A.L. Vataire is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A.L. Vataire has authored 34 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in A.L. Vataire's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (9 papers) and Economic and Financial Impacts of Cancer (7 papers). A.L. Vataire is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (9 papers) and Economic and Financial Impacts of Cancer (7 papers). A.L. Vataire collaborates with scholars based in France, United Kingdom and United States. A.L. Vataire's co-authors include Samuel Aballéa, Jean‐Pierre Pignon, Jean‐Charles Soria, Ariane Dunant, Mondher Toumi, Nicolas Magné, Gilles Vassal, Antoîne Italiano, Ratislav Bahleda and Jean‐Pierre Armand and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

A.L. Vataire

33 papers receiving 468 citations

Peers

A.L. Vataire
Janet L. Espirito United States
A. de Boer Netherlands
Jaclyn Beca Canada
Paul You United States
Emmanuelle Kempf France
Diana T. Chingos United States
Simran Padam United States
Pasquale Lombardi Italy
Nathan C. Nussbaum United States
Melisa Tucker United States
Janet L. Espirito United States
A.L. Vataire
Citations per year, relative to A.L. Vataire A.L. Vataire (= 1×) peers Janet L. Espirito

Countries citing papers authored by A.L. Vataire

Since Specialization
Citations

This map shows the geographic impact of A.L. Vataire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Vataire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Vataire more than expected).

Fields of papers citing papers by A.L. Vataire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.L. Vataire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Vataire. The network helps show where A.L. Vataire may publish in the future.

Co-authorship network of co-authors of A.L. Vataire

This figure shows the co-authorship network connecting the top 25 collaborators of A.L. Vataire. A scholar is included among the top collaborators of A.L. Vataire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.L. Vataire. A.L. Vataire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Read, Stephanie H., Nadia Quignot, Ying Zheng, et al.. (2024). Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database. Breast Cancer Research and Treatment. 204(3). 579–588. 4 indexed citations
2.
3.
4.
Chang, Bernard, et al.. (2018). Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective. BMC Ophthalmology. 18(1). 104–104. 13 indexed citations
5.
6.
Elborn, J.S., A.L. Vataire, Ayako Fukushima, et al.. (2016). Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis. Clinical Therapeutics. 38(10). 2204–2226. 44 indexed citations
7.
Homøe, Preben, et al.. (2015). Does drinking water influence hospital-admitted sialolithiasis on an epidemiological level in Denmark?. BMJ Open. 5(4). e007385–e007385. 11 indexed citations
8.
Rémuzat, C., et al.. (2014). Price Dynamics Of External Reference Pricing-Based Systems In Europe. Value in Health. 17(3). A11–A11. 3 indexed citations
9.
Ma, Xiaoli, Vanessa Rousseau, Haiji Sun, et al.. (2014). Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer. Molecular Oncology. 8(3). 555–564. 35 indexed citations
10.
Vataire, A.L., Samuel Aballéa, Fernando Antoñanzas, et al.. (2014). Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder. Value in Health. 17(2). 183–195. 8 indexed citations
11.
Rémuzat, C., et al.. (2013). Pharmaceutical Expenditure Forecast Model To Support Health Policy Decision Making. Value in Health. 16(3). A255–A255. 3 indexed citations
12.
13.
Rémuzat, C., et al.. (2013). EU Pharmaceutical Expenditure Forecast. Value in Health. 16(3). A254–A255. 5 indexed citations
14.
Rémuzat, C., et al.. (2013). Innovative Methodology For Pharmaceutical Expenditure Forecast. Value in Health. 16(3). A256–A256. 1 indexed citations
15.
Vataire, A.L., Enora Laas, Samuel Aballéa, et al.. (2012). Analyse coût-efficacité d’un test prédictif de la chimiothérapie dans le cancer du sein (Oncotype DX®) en France. Bulletin du Cancer. 99(10). 907–914. 22 indexed citations
16.
Toumi, Mondher, Fernando Antoñanzas, Leona Hakkaart‐van Roijen, et al.. (2012). MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression. Value in Health. 15(7). A282–A282. 1 indexed citations
17.
Laas, Enora, A.L. Vataire, Samuel Aballéa, et al.. (2012). PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy. Value in Health. 15(7). A354–A354. 2 indexed citations
18.
Bepler, Gerold, Ken A. Olaussen, A.L. Vataire, et al.. (2011). ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis. American Journal Of Pathology. 178(1). 69–78. 43 indexed citations
19.
Bourgier, C., A.L. Vataire, Ariane Dunant, et al.. (2010). Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. Radiotherapy and Oncology. 96(2). 199–203. 40 indexed citations
20.
Italiano, Antoîne, Christophe Massard, Ratislav Bahleda, et al.. (2007). Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy. Annals of Oncology. 19(4). 787–792. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet L. Espirito Breakdown of academic impact, for papers by A. de Boer Breakdown of academic impact, for papers by Jaclyn Beca Breakdown of academic impact, for papers by Paul You Breakdown of academic impact, for papers by Emmanuelle Kempf Breakdown of academic impact, for papers by Diana T. Chingos Breakdown of academic impact, for papers by Simran Padam Breakdown of academic impact, for papers by Pasquale Lombardi Breakdown of academic impact, for papers by Nathan C. Nussbaum Breakdown of academic impact, for papers by Melisa Tucker
Rankless by CCL
2026